Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

299.61
Delayed Data
As of Sep 02
 +5.40 / +1.84%
Today’s Change
208.64
Today|||52-Week Range
340.34
+16.39%
Year-to-Date

Today’s Trading

Previous close294.21
Today’s open298.84
Day’s range293.00 - 302.00
Volume2,314,266
Average volume (3 months)2,294,700
Market cap$115.8B
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+25.23%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+1.15+2.12%
SNYSanofi+1.12+2.33%
ABBVAbbVie+0.48+0.79%
BMYBristol-Myers Squibb+1.41+2.42%
Data as of 09/02/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)$4.23
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers